TG Therapeutics, Inc. (NASDAQ:TGTX) Q3 2024 Earnings Call Transcript November 4, 2024
TG Therapeutics, Inc. misses on earnings expectations. Reported EPS is $0.02 EPS, expectations were $0.03.
Operator: Greetings, and welcome to the TG Therapeutics’ Third Quarter Conference Call and Webcast. At this time, all participants are in a listen-only mode. [Operator Instructions] A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference...
